SU-E-T-586: Brachytherapy Application with in Situ Dose-Painting Administered Via Gold-Nanoparticle Eluters (BANDAGE) for Prostate Cancer (PCa)

2013 ◽  
Vol 40 (6Part20) ◽  
pp. 340-340
Author(s):  
N Sinha ◽  
E Sajo ◽  
H Korideck ◽  
G Makrigiorgos ◽  
W Ngwa
Keyword(s):  
Prostate Cancer ◽  
Gold Nanoparticle ◽  
Dose Painting

scholarly journals Brachytherapy Application With In Situ Dose Painting Administered by Gold Nanoparticle Eluters

2015 ◽  
Vol 91 (2) ◽  
pp. 385-392 ◽  
Author(s):  
Neeharika Sinha ◽  
Gizem Cifter ◽  
Erno Sajo ◽  
Rajiv Kumar ◽  
Srinivas Sridhar ◽  
...  
Keyword(s):  
Gold Nanoparticle ◽  
Dose Painting

Basal Cell Carcinoma of Prostate With MSMB–NCOA4 Fusion and a Probable Basal Cell Carcinoma In Situ: Case Report

2021 ◽  
pp. 106689692110173
Author(s):  
Vilde Pedersen ◽  
Katrine S. Petersen ◽  
Klaus Brasso ◽  
Olga Østrup ◽  
Anand C. Loya
Keyword(s):  
Prostate Cancer ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Carcinoma In Situ ◽  
Pathological Examination ◽  
Molecular Characteristics ◽  
Histological Lesion ◽  
Basal Cell Carcinomas

Basal cell carcinomas of prostate (BCCP) are very rare. Most arise in the transition zone and thus are associated with lower urinary tract symptoms and rarely associated with elevated prostate-specific antigen (PSA). These features make diagnosis/early diagnosis difficult because of the routine protocols followed. Basal cell carcinomas have distinctive histopathological, immunohistochemical, and to some extent also different molecular characteristics. Basal cell carcinoma in situ (BCCIS) is a nonexistent histological lesion as per the current literature, but here is an attempt to describe it through this case. A 74-year-old man presented with hematuria and previous diagnosis of prostatic hyperplasia. Based on this history, he underwent a prostatectomy ad modum Freyer. Pathological examination surprisingly revealed a diffusely infiltrative tumor with nonacinar adenocarcinoma morphology and many glandular structures probably representing BCCIS. Tumor was diagnosed as BCCP. Patient presented with metastasis to the abdominal wall 8 months postprostatectomy. BCCP is an aggressive type of prostate cancer, which might be challenging to diagnose based on routine protocols. This results in delayed diagnosis and treatment and thus poor prognosis. Furthermore, patients with this subtype of prostate cancer need appropriately designed, and maybe a totally different follow-up regimen as PSA is of no use for BCCP patients. Finally, diagnosis of BCCIS, if agreed upon its existence needs to be studied in larger cohorts as a precursor lesion.

In Situ Observation of Plasmon Tuning in a Single Gold Nanoparticle during Controlled Melting

Nano Letters ◽  
2013 ◽  
Vol 13 (5) ◽  
pp. 2041-2046 ◽  
Author(s):  
Alexander Kuhlicke ◽  
Stefan Schietinger ◽  
Christian Matyssek ◽  
Kurt Busch ◽  
Oliver Benson
Keyword(s):  
Gold Nanoparticle ◽  
In Situ Observation

Mechanism of Gold Nanoparticle Formation in the Classical Citrate Synthesis Method Derived from Coupled In Situ XANES and SAXS Evaluation

2010 ◽  
Vol 132 (4) ◽  
pp. 1296-1301 ◽  
Author(s):  
Jörg Polte ◽  
T. Torsten Ahner ◽  
Friedmar Delissen ◽  
Sergey Sokolov ◽  
Franziska Emmerling ◽  
...  
Keyword(s):  
Gold Nanoparticle ◽  
Synthesis Method ◽  
Nanoparticle Formation ◽  
In Situ Xanes

scholarly journals Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer

2015 ◽  
Vol 21 (11) ◽  
pp. 2591-2600 ◽  
Author(s):  
Peter Blume-Jensen ◽  
David M. Berman ◽  
David L. Rimm ◽  
Michail Shipitsin ◽  
Mathew Putzi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Risk Stratification ◽  
Clinical Validation

scholarly journals Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model

2005 ◽  
Vol 13 (1) ◽  
pp. 91-98 ◽  
Author(s):  
T Saika ◽  
N Kusaka ◽  
V Mouraviev ◽  
T Satoh ◽  
H Kumon ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Gene Therapy ◽  
Therapeutic Effects ◽  
Cancer Model ◽  
Mouse Prostate ◽  
Prostate Cancer Model
Sign in / Sign up

Export Citation Format

Share Document